Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO)
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (7) , 992-998
- https://doi.org/10.1016/s0959-8049(98)00021-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgeryEuropean Journal of Anaesthesiology, 1997
- The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialTransfusion, 1996
- Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancerThe Lancet, 1994
- The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy‐induced anemia in autologous blood donorsTransfusion, 1993
- Feasibility of a Predeposit Autologous Blood Donation Program in Colorectal Cancer Patients: Results from a Randomized Clinical StudyVox Sanguinis, 1992
- The effect of oral iron supplementation on erythropoiesis in autologous blood donorsTransfusion, 1992
- Autologous blood transfusion with recombinant human erythropoietin in heart operationsThe Annals of Thoracic Surgery, 1991
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Der Einflu der Transfusion von Blut and Haemoderivaten auf die Prognose des colorectalen CarcinomsLangenbecks Archives Of Surgery, 1989
- Effect of blood transfusions on immune function: IV. Effect on tumor growthJournal of Surgical Oncology, 1988